1 |
Qin Y, Ren S, Shao B, Qin H, Wang H, Li G, Zhu Y, Sun C, Li C, Zhang J, Wang H. The intellectual base and research fronts of IL-37: A bibliometric review of the literature from WoSCC. Front Immunol 2022;13:931783. [DOI: 10.3389/fimmu.2022.931783] [Reference Citation Analysis]
|
2 |
Zhu Y, Qin H, Ye K, Sun C, Qin Y, Li G, Wang H, Wang H. Dual role of IL-37 in the progression of tumors. Cytokine 2021;150:155760. [PMID: 34800851 DOI: 10.1016/j.cyto.2021.155760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Bai XS, Zhang C, Peng R, Jiang GQ, Jin SJ, Wang Q, Ke AW, Bai DS. RNF128 Promotes Malignant Behaviors via EGFR/MEK/ERK Pathway in Hepatocellular Carcinoma. Onco Targets Ther 2020;13:10129-41. [PMID: 33116595 DOI: 10.2147/OTT.S269606] [Reference Citation Analysis]
|
4 |
Sun D, Cao H, Yang L, Lin L, Hou B, Zheng W, Shen Z, Song H. MiR-200b in heme oxygenase-1-modified bone marrow mesenchymal stem cell-derived exosomes alleviates inflammatory injury of intestinal epithelial cells by targeting high mobility group box 3. Cell Death Dis 2020;11:480. [PMID: 32587254 DOI: 10.1038/s41419-020-2685-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|